Search Results 21-30 of 16156 for Whipple's disease
... (AMP-514). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.
Pertuzumab and trastuzumab are monoclonal antibodies and ... (AMP-514) in participants with relapsed or ... and validate the methylome profiling platform to detect ...
... disorders to evaluate your condition and symptoms over time and diagnose Parkinson's disease. ... This study of the alpha-synuclein seed amplification assay was ...
This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...
... Whipple's disease, and other miscellaneous inflammatory disorders of the small intestine. This resource will be invaluable in answering the important ...
Diseases & Conditions · Symptoms · Tests & Procedures ... This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP ...
This inherited disease causes copper to build up in vital organs, especially the liver, brain and eyes. It's treatable when caught early.
A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.